Edward M. Kaye MD - Director at Stoke Therapeutics, Inc.
Insider Transactions and Holdings
- Entity Type
- Individual
- Role
- Director
- Issuer Symbol
- STOK on Nasdaq
- All Insider Reports
- All Insider Reports
Edward M. Kaye MD - trading volume in the past year for Stoke Therapeutics, Inc.
| Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|
| Buys | ||||
| Sells | -172,039 | 100% | $24.69 | -$4,246,943 |
| Net | -172,039 | -100% | -$4,246,943 |
Holdings reported by Edward M. Kaye MD for Stoke Therapeutics, Inc.
| Security | Num Shares | Value | Price $ | Transaction Date | Ownership | Underlying Class | Underlying Amount |
|---|---|---|---|---|---|---|---|
| Common Stock | 110,874 | $3,941,570 | $35.55 | 15 Mar 2026 | Direct | ||
| Restricted Stock Units | 52,500 | $1,190,880 | $8.27 | 15 Mar 2026 | Direct | Common Stock | |
| Performance Stock Units | 0 | $316,832 | $12.07 | 03 Dec 2025 | Direct | Common Stock | |
| Stock Option (Right to Buy) | 542,801 | 08 Oct 2025 | Direct | Common Stock | |||
| Employee Stock Option (Right to Buy) | 37,500 | 04 Sep 2025 | Direct | Common Stock |
Transactions reported by Edward M. Kaye MD for Stoke Therapeutics, Inc.
| Sym | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.